Return to Publications
June 2018
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Deborah Toppmeyer, MD

A New Look at the Need for Chemotherapy in Common Form of Breast Cancer

A study just published in the New England Journal of Medicineexploring a gene test suggests that chemotherapy may be avoided for more than two-thirds of women with the most common type of breast cancer. Rutgers Cancer Institute of New Jersey Chief Medical OfficerDeborah Toppmeyer, MD, who is the director of both the Stacy Goldstein Breast Cancer Center and LIFE Center at Rutgers Cancer Institute and a professor of medicine at Rutgers Robert Wood Johnson Medical School, is among the study collaborators. The research was led by the ECOG-ACRIN Cancer Research Group and presented at the recent American Society of Clinical Oncology Annual Meeting.


Rutgers Researchers Help Validate Method to Identify Antibodies that Target Tumors

The development of targeted tools for therapy is a major focus in oncology. A new study by investigators at Rutgers Cancer Institute of New Jersey at University Hospital, Rutgers New Jersey Medical School and other collaborators describes what they call a "major advance" to a screening technique they pioneered that searches for molecular signatures intrinsic to normal or diseased tissues.

conference group

Improving Screening Opportunities and Awareness for Colorectal and Lung Cancers

Health care providers, community members, and researchers from across the state came together recently at the 'Conference for Change' event, hosted by the New Jersey Primary Care Association and sponsored by ScreenNJ - a prevention and education program led by Rutgers Cancer Institute of New Jersey and the New Jersey Department of Health. Participants discussed comprehensive strategies to increase screening rates for colorectal and lung cancers, the importance of tobacco cessation, and enhancing clinical practices. Data gathered at the conference will be developed into recommendations for the ScreenNJ program.

nursing research

Aiming to Improve Oncology Patient Outcomes through Nursing Research

From peer and patient education to addressing treatment side effects, nurses at Rutgers Cancer Institute of New Jersey researched a number of topics with an aim of enhancing the patient experience. They also examined patient-centered care approaches to palliative care, as well as spiritual well-being and how that is assessed and documented. The reinstitution of a nursing preceptor course also was explored. Their findings were recently presented at the Oncology Nursing Society's Annual Congress meeting.

Howard Hochster, MD, FACP

Exploring Targeted Second-Line Therapy for Advanced Colorectal Cancer

Targeted therapy with anti-VEGF and anti-EGFR antibodies both improve outcomes when added to chemotherapy in the treatment of colorectal cancer. However, some previous studies suggested that when combined they may have a negative interaction. ECOG-ACRIN Cancer Research Group investigators led by Howard S. Hochster, MD, FACP, associate director for clinical research and director of gastrointestinal oncology at Rutgers Cancer Institute of New Jersey, explored the anti-VEGFR antibody ramucirumab in second-line treatment in patients with KRAS mutations. The work was presented at the recent American Society of Clinical Oncology Annual Meeting.


Analysis: Lymph Node Dissection Performed most often for Early Stage Kidney Cancer

An analysis of lymph node dissection in non-metastatic renal cell carcinoma indicates the procedure is often performed for stage 1 disease and shows no overall survival benefit. Rutgers Cancer Institute of New Jersey urologic oncologist Eric Singer, MD, MA, FACS, who is also an assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, and colleagues presented the work recently at the Annual Meeting of the American Urological Association.